BSE Live
Mar 02, 16:01Prev. Close
4.43
Open Price
4.43
Bid Price (Qty.)
4.43 (83500)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Cresanto Global (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -0.13 | -0.13 | -0.13 | -0.12 | -0.09 | |
| Diluted EPS (Rs.) | -0.13 | -0.13 | -0.13 | -0.12 | -0.09 | |
| Cash EPS (Rs.) | -0.12 | -0.11 | -0.12 | -0.10 | -0.07 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | -4.64 | -4.51 | -4.39 | -4.25 | -4.14 | |
| Book Value [InclRevalReserve]/Share (Rs.) | -4.64 | -4.51 | -4.39 | -4.25 | -4.14 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PBDIT/Share (Rs.) | -0.04 | -0.04 | -0.05 | -0.05 | -0.01 | |
| PBIT/Share (Rs.) | -0.05 | -0.06 | -0.07 | -0.06 | -0.04 | |
| PBT/Share (Rs.) | -0.13 | -0.13 | -0.13 | -0.12 | -0.09 | |
| Net Profit/Share (Rs.) | -0.13 | -0.13 | -0.13 | -0.12 | -0.09 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PBIT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PBT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Profit Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Return on Networth / Equity (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Return on Capital Employed (%) | 1.17 | 1.24 | 1.48 | 1.48 | 0.85 | |
| Return on Assets (%) | -21.67 | -20.20 | -20.95 | -18.05 | -13.44 | |
| Total Debt/Equity (X) | -1.02 | -1.04 | -1.06 | -1.09 | -1.12 | |
| Asset Turnover Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | |
| Quick Ratio (X) | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 2.43 | 2.98 | 2.94 | 3.08 | 3.32 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | -141.19 | -168.48 | -138.84 | -154.51 | -545.35 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | -0.21 | -0.51 | -0.51 | -0.61 | -0.76 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | -0.13 | -0.05 | -0.06 | -0.04 | -0.03 |
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth